Clinical Significance of Auditive Involvement in Rheumatoid Arthritis: A Case-Control Study

Table 1

Demographic characteristics of the populations under study.

Characteristic	Cases	Controls
𝑁	45	45
Gender; (feminine)	41 (91.1%)	41 (91.1%)
Age (years); (mean ± SD)*	44.1 (11.9)	44.4 (12)
Comorbilidity (𝑛)	Dyslipidemia (1)	Dyslipidemia (1)
	Systemic high blood pressure (4)	Systemic high blood pressure (2)
	Diabetes mellitus (2)
Categorization by age (years), 𝑛 (%)
<35	12 (27)	13 (28.9)
>35	33 (73)	32 (71.1)
DAS 28, 𝑛 (%)
Inactive	8 (18)
Slight activity	9 (20)
Moderate activity	19 (42)
Severe activity	9 (20)
RA evolution (years),; 𝑛 (%)
<2	10 (22)
2–5	14 (31)
5–10	10 (22)
>10	11 (25)
Drugs utilized, 𝑛 (%)
Methotrexate	35 (78)
Hydroxychloroquine/; chloroquine	24 (53)
Anti-TNF	7 (15)
Leflunomide	6 (13)
Sulfasalazine	6 (13)
Rituximab	5 (11)
Steroids	11 (24)
NSAID	33 (73)

*Age difference between groups (𝑃=0.27). SD: standard deviation; Disease Activity Score: DAS 28; Antitumoral necrosis Factor: Anti-TNF; NSAID: nonsteroidal anti-inflammatory.